# Treating Postmenopausal Dyspareunia Where it Hurts

> **NCT03240081** · PHASE4 · COMPLETED · sponsor: **Oregon Health and Science University** · enrollment: 50 (actual)

## Conditions studied

- Dyspareunia

## Interventions

- **DRUG:** 50mcg estradiol cream
- **DRUG:** 100mcg estradiol cream

## Key facts

- **NCT ID:** NCT03240081
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-20
- **Primary completion:** 2019-11-21
- **Final completion:** 2019-11-21
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2023-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03240081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03240081, "Treating Postmenopausal Dyspareunia Where it Hurts". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03240081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*